Beam Therapeutics (BEAM)
(Real Time Quote from BATS)
$26.75 USD
-0.54 (-1.98%)
Updated Jul 17, 2024 01:00 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Brokerage Reports
Beam Therapeutics Inc. [BEAM]
Reports for Purchase
Showing records 81 - 100 ( 121 total )
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Q2:21: Will There Be a Gold in the BEAM Going into Year End?
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: Beam Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
BEAM-201 Development Candidate--Allo Cell Therapy for TALL
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D